What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
Cytokine release syndrome: a limiting factor for AML treatment
The need for collaboration amongst hospitals: learning from RATIFY
The 20th anniversary of the German CLL Study Group and the importance of collaboration
Updates from current CLL clinical trials